Inventor · disambiguated record
Soonmyung Paik
Also filed as: PAIK SOONMYUNG
20 granted patents·16 pending applications·564 citations·filing 2004–2020
96Inventor score
Top patents by PatentIndex Score
36 records- 0198US7930104B2Predicting response to chemotherapy using gene expression markersGENOMIC HEALTH INC·Filed 2005·Granted Apr 19, 2011·91 cites·24 claims
- 0297US7695913B2Gene expression markers for colorectal cancer prognosisGENOMIC HEALTH INC·Filed 2007·Granted Apr 13, 2010·50 cites·18 claims
- 0396US8029995B2Gene expression markers for colorectal cancer prognosisGENOMIC HEALTH INC·Filed 2010·Granted Oct 4, 2011·18 cites·16 claims
- 0496US8026060B2Gene expression markers for colorectal cancer prognosisGENOMIC HEALTH INC·Filed 2010·Granted Sep 27, 2011·18 cites·16 claims
- 0596US7723033B2Prediction of likelihood of cancer recurrenceGENOMIC HEALTH INC·Filed 2006·Granted May 25, 2010·28 cites·12 claims
- 0695US7056674B2Prediction of likelihood of cancer recurrenceNSABP FOUNDATION INC·Filed 2004·Granted Jun 6, 2006·148 cites·10 claims
- 0794US8198024B2Gene expression markers for colorectal cancer prognosisWATSON DREW·Filed 2011·Granted Jun 12, 2012·13 cites·16 claims
- 0894US7939261B2Expression profile algorithm and test for cancer prognosisGENOMIC HEALTH INC·Filed 2009·Granted May 10, 2011·25 cites·29 claims
- 0994US7622251B2Molecular indicators of breast cancer prognosis and prediction of treatment responseGENOMIC HEALTH INC·Filed 2005·Granted Nov 24, 2009·31 cites·12 claims
- 1093US8153379B2Gene expression markers for colorectal cancer prognosisWATSON DREW·Filed 2010·Granted Apr 10, 2012·11 cites·17 claims
- 1193US8153378B2Gene expression markers for colorectal cancer prognosisCOWENS WAYNE·Filed 2010·Granted Apr 10, 2012·11 cites·18 claims
- 1293US8153380B2Gene expression markers for colorectal cancer prognosisWATSON DREW·Filed 2010·Granted Apr 10, 2012·11 cites·18 claims
- 1393US8067178B2Gene expression markers for prediction of patient response to chemotherapyBAKER JOFFRE B·Filed 2009·Granted Nov 29, 2011·24 cites·13 claims
- 1492US8273537B2Gene expression markers for colorectal cancer prognosisWATSON DREW·Filed 2010·Granted Sep 25, 2012·8 cites·16 claims
- 1592US7526387B2Expression profile algorithm and test for cancer prognosisGENOMIC HEALTH INC·Filed 2004·Granted Apr 28, 2009·47 cites·36 claims
- 1691US8632980B2Gene expression markers for prediction of patient response to chemotherapyBAKER JOFFRE B·Filed 2011·Granted Jan 21, 2014·10 cites·18 claims
- 1791US8367345B2Gene expression markers for colorectal cancer prognosisGENOMIC HEALTH INC·Filed 2012·Granted Feb 5, 2013·8 cites·20 claims
- 1888US8868352B2Predicting response to chemotherapy using gene expression markersBAKER JOFFRE B·Filed 2011·Granted Oct 21, 2014·10 cites·21 claims
- 1975US10166210B2Methods of subtyping CRC and their association with treatment of colon cancer patients with oxaliplatinNSABP FOUND INC·Filed 2015·Granted Jan 1, 2019·2 cites·6 claims
- 2071US10619215B2Prediction of likelihood of cancer recurrenceGENOMIC HEALTH INC·Filed 2017·Granted Apr 14, 2020·0 cites·11 claims
- 2171US2020299781A1Prediction of Likelihood of Cancer RecurrenceGENOMIC HEALTH INC·Filed 2020·Application pending·0 cites
- 2270US2010184041A1Molecular Indicators of Breast Cancer Prognosis and Prediction of Treatment ResponseBAKER JOFFRE B·Filed 2009·Application pending·0 cites
- 2361US2009304697A1Identification and use of prognostic and predictive markers in cancer treatmentNSABP FOUNDATION INC·Filed 2009·Application pending·0 cites
- 2461US2013102492A1Gene expression markers for colorectal cancer prognosisGENOMIC HEALTH INC·Filed 2012·Application pending·0 cites
- 2561US2010267032A1Prediction of Likelihood of Cancer RecurrenceBAKER JOFFRE B·Filed 2010·Application pending·0 cites
- 2659US2015079591A1Predicting response to chemotherapy using gene expression markersGENOMIC HEALTH INC·Filed 2014·Application pending·0 cites
- 2757US2006127935A1Identification and use of prognostic and predictive markers in cancer treatmentNSABP FOUNDATION INC·Filed 2005·Application pending·0 cites
- 2856US2014206545A1Gene expression markers for prediction of patient response to chemotherapyNSABP FOUNDATION INC·Filed 2013·Application pending·0 cites
- 2955US2009035311A1Identification and use of prognostic and predictive markers in cancer treatmentNSABP FOUNDATION INC·Filed 2008·Application pending·0 cites
- 3052US2019076391A1Methods of Subtyping CRC and their association with Treatment of Colon Cancer Patients With OxaliplatinNSABP FOUND INC·Filed 2018·Application pending·0 cites
- 3148US2009258795A1Gene expression markers for prediction of patient response to chemotherapyGENOMIC HEALTH INC·Filed 2008·Application pending·0 cites
- 3248US2023021094A1Composition for predicting response to standard preoperative chemoradiation therapy and prognosis following treatment, and method and composition for predicting patients with very unsatisfactory prognoses following standard therapyNOVOMICS CO LTD·Filed 2020·Application pending·0 cites
- 3343US2014348821A1Defective Mismatch Repair and Benefit from Bevacizumab for Colon CancerNSABP FOUNDATION INC·Filed 2014·Application pending·0 cites
- 3442US2007254305A1Methods of whole genome or microarray expression profiling using nucleic acids prepared from formalin fixed paraffin embedded tissueNSABP FOUNDATION INC·Filed 2007·Application pending·0 cites
- 3540US2013251710A1Methods to Expand the Eligible Patient Population for HER2-Directed Targeted TherapiesNSABP FOUNDATION INC·Filed 2013·Application pending·0 cites
- 3632US2011262434A1Methods to Expand the Eligible Patient Population for HER2-Directed Targeted TherapiesNSABP FOUNDATION INC·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →